JMP Securities initiated coverage on KalVista Pharmaceuticals with a new price target

1/31/25 7:03:28 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

JMP Securities initiated coverage of KalVista Pharmaceuticals with a rating of Mkt Outperform and set a new price target of $19.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$KALV

Date	Price Target	Rating	Analyst
1/31/2025	$19.00	Mkt Outperform	JMP Securities
1/7/2025	$30.00	Buy	TD Cowen
12/18/2024	$22.00	Buy	BofA Securities
3/11/2022	$48.00 → $42.00	Buy	Needham
12/10/2021	$50.00 → $48.00	Buy	Needham